Search Results - "Xia, Karen"
-
1
A phase 2a study of toreforant, a histamine H4 receptor antagonist, in eosinophilic asthma
Published in Annals of allergy, asthma, & immunology (01-11-2018)“…Data from preclinical and clinical studies support the evaluation of histamine 4 receptor antagonists in the treatment of asthma. Toreforant is a selective…”
Get full text
Journal Article -
2
Seasonal impact of regional outdoor biomass burning on air pollution in three Indian cities: Delhi, Bengaluru, and Pune
Published in Atmospheric environment (1994) (01-01-2018)“…Air pollution in many of India's cities exceeds national and international standards, and effective pollution control strategies require knowledge of the…”
Get full text
Journal Article -
3
A phase 2a study of toreforant, a histamine H 4 receptor antagonist, in eosinophilic asthma
Published in Annals of allergy, asthma, & immunology (01-11-2018)“…Data from preclinical and clinical studies support the evaluation of histamine 4 receptor antagonists in the treatment of asthma. Toreforant is a selective…”
Get full text
Journal Article -
4
CUTANEOUS TOXICITIES WITH AMIVANTAMAB FOR NON-SMALL CELL LUNG CANCER (NSCLC) WITH EXON 20 INSERTION MUTATION (EX20INS): A PRACTICAL GUIDE AND BEST PRACTICES FOR MANAGEMENT
Published in Oncology nursing forum (01-03-2023)“…Amivantamab, an EGFR-MET bispecific antibody, is an approved treatment for patients with ex20ins advanced NSCLC post platinum chemotherapy. These patients have…”
Get full text
Journal Article -
5
Efficacy and safety of erdafitinib in adults with NSCLC and prespecified fibroblast growth factor receptor alterations in the phase 2 open-label, single-arm RAGNAR trial
Published in Journal of clinical oncology (01-06-2024)“…8515 Background: Erdafitinib is an oral selective pan-fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitor approved in the US for treatment of…”
Get full text
Journal Article -
6
Cutaneous Toxicities With Amivantamab for Non-Small Cell Lung Cancer: A Practical Guide and Best Practices
Published in Clinical journal of oncology nursing (01-10-2024)“…Amivantamab is an epidermal growth factor receptor (EGFR) and MET bispecific antibody approved for certain patients with advanced non-small cell lung cancer…”
Get full text
Journal Article -
7
3-LB: Golimumab (GLM) Preserves ß-Cell Function and Reduces Insulin Use and Hypoglycemia in Children and Young Adults with Recently Diagnosed Type 1 Diabetes (T1D): The Phase 2 T1GER Study
Published in Diabetes (New York, N.Y.) (01-06-2020)“…T1D is an autoimmune disease characterized by progressive loss of pancreatic β cells. GLM is a human IgG1κ monoclonal antibody specific for tumor necrosis…”
Get full text
Journal Article -
8
Seasonal Impact of Regional Outdoor Biomass Burning on Air Pollution in Three Indian Cities: Delhi, Bengaluru, and Pune
Published in Atmospheric environment (1994) (02-11-2017)“…Air pollution in many of India's cities exceeds national and international standards, and effective pollution control strategies require knowledge of the…”
Get full text
Journal Article -
9
Dexamethasone Reduces IL-17 and Tim-3 Expression in BALF of Asthmatic Mice
Published in Journal of Huazhong University of Science and Technology. Medical sciences (01-08-2013)“…Summary: This study investigated the expression of interleukin-17 (IL-17) and T cell immunoglobulin mucin and domain-containing molecule-3 (Tim-3) in…”
Get full text
Journal Article